Joinn Laboratories(China)Co.,Ltd. (HKG:6127)
12.18
-0.38 (-3.03%)
Apr 3, 2025, 4:08 PM HKT
HKG:6127 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 2,018 | 2,376 | 2,268 | 1,517 | 1,076 | Upgrade
|
Revenue | 2,018 | 2,376 | 2,268 | 1,517 | 1,076 | Upgrade
|
Revenue Growth (YoY) | -15.07% | 4.78% | 49.54% | 40.97% | 68.27% | Upgrade
|
Cost of Revenue | 1,445 | 1,395 | 1,184 | 778.89 | 524.6 | Upgrade
|
Gross Profit | 573.77 | 981.55 | 1,084 | 737.79 | 551.3 | Upgrade
|
Selling, General & Admin | 317.06 | 304.87 | 304.6 | 272.13 | 221.54 | Upgrade
|
Research & Development | 92.92 | 96.85 | 77.98 | 47.76 | 50.66 | Upgrade
|
Other Operating Expenses | -17.55 | -3.32 | 1.98 | 1.26 | 0.66 | Upgrade
|
Operating Expenses | 411.57 | 408.4 | 390.14 | 321.97 | 270.11 | Upgrade
|
Operating Income | 162.2 | 573.16 | 693.38 | 415.82 | 281.2 | Upgrade
|
Interest Expense | -2.45 | -3.14 | -3.58 | -3.96 | -0.84 | Upgrade
|
Interest & Investment Income | 139.24 | 152.13 | 144.26 | 100.72 | 3.6 | Upgrade
|
Currency Exchange Gain (Loss) | - | 12.11 | 27.4 | -60.33 | -3.38 | Upgrade
|
Other Non Operating Income (Expenses) | -1.32 | -0.71 | -0.59 | -0.76 | -0.37 | Upgrade
|
EBT Excluding Unusual Items | 297.68 | 733.54 | 860.87 | 451.5 | 280.22 | Upgrade
|
Gain (Loss) on Sale of Investments | -127.05 | -245.64 | 349.57 | 157.78 | 58.95 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.05 | -0.25 | -0.41 | -0.41 | -0.31 | Upgrade
|
Asset Writedown | -66.54 | - | - | - | - | Upgrade
|
Other Unusual Items | - | 19.3 | 29.98 | 33.14 | 21.72 | Upgrade
|
Pretax Income | 104.04 | 506.95 | 1,240 | 642 | 360.57 | Upgrade
|
Income Tax Expense | 34.28 | 115.4 | 166.8 | 85.59 | 46.94 | Upgrade
|
Earnings From Continuing Operations | 69.76 | 391.55 | 1,073 | 556.42 | 313.63 | Upgrade
|
Minority Interest in Earnings | 4.32 | 5.44 | 1.06 | 1.04 | 1.39 | Upgrade
|
Net Income | 74.08 | 396.99 | 1,074 | 557.46 | 315.01 | Upgrade
|
Net Income to Common | 74.08 | 396.99 | 1,074 | 557.46 | 315.01 | Upgrade
|
Net Income Growth | -81.34% | -63.04% | 92.71% | 76.96% | 68.67% | Upgrade
|
Shares Outstanding (Basic) | 741 | 749 | 746 | 723 | 617 | Upgrade
|
Shares Outstanding (Diluted) | 741 | 749 | 751 | 729 | 624 | Upgrade
|
Shares Change (YoY) | -1.11% | -0.29% | 3.00% | 16.95% | 1.01% | Upgrade
|
EPS (Basic) | 0.10 | 0.53 | 1.44 | 0.77 | 0.51 | Upgrade
|
EPS (Diluted) | 0.10 | 0.53 | 1.43 | 0.76 | 0.51 | Upgrade
|
EPS Growth | -81.13% | -62.94% | 87.10% | 51.32% | 66.97% | Upgrade
|
Free Cash Flow | 69.54 | 430.15 | 696.23 | 448.41 | 279.41 | Upgrade
|
Free Cash Flow Per Share | 0.09 | 0.57 | 0.93 | 0.61 | 0.45 | Upgrade
|
Dividend Per Share | - | 0.160 | 0.286 | 0.184 | 0.128 | Upgrade
|
Dividend Growth | - | -44.00% | 55.61% | 43.89% | 44.18% | Upgrade
|
Gross Margin | 28.43% | 41.30% | 47.77% | 48.64% | 51.24% | Upgrade
|
Operating Margin | 8.04% | 24.12% | 30.57% | 27.42% | 26.14% | Upgrade
|
Profit Margin | 3.67% | 16.71% | 47.37% | 36.75% | 29.28% | Upgrade
|
Free Cash Flow Margin | 3.45% | 18.10% | 30.70% | 29.57% | 25.97% | Upgrade
|
EBITDA | 263.83 | 671.77 | 790.39 | 490.27 | 341.85 | Upgrade
|
EBITDA Margin | 13.07% | 28.27% | 34.85% | 32.32% | 31.77% | Upgrade
|
D&A For EBITDA | 101.63 | 98.61 | 97.01 | 74.45 | 60.65 | Upgrade
|
EBIT | 162.2 | 573.16 | 693.38 | 415.82 | 281.2 | Upgrade
|
EBIT Margin | 8.04% | 24.12% | 30.57% | 27.42% | 26.14% | Upgrade
|
Effective Tax Rate | 32.95% | 22.76% | 13.45% | 13.33% | 13.02% | Upgrade
|
Revenue as Reported | 2,018 | 2,376 | 2,268 | 1,517 | 1,076 | Upgrade
|
Advertising Expenses | - | 4.51 | 1.49 | 1.42 | 1.24 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.